Recent Advances in RNA‐Targeted Cancer Therapy
ChemBioChem · 16.02.2024 · 25 (4)
DOI: 10.1002/cbic.202300633 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift ChemBioChem, online erschienen am 04.12.2023. Verfasst von Miao Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovatio…. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Invigorating Medical through Science and Technology of Shanxi Province, State Key Laboratory of Radiation Medicine and Protection.
Abstract (Originalsprache)
Ribonucleic acid (RNA) plays a pivotal role in gene regulation and protein biosynthesis. Interfering the physiological function of key RNAs to induce cell apoptosis holds great promise for cancer treatment. Many RNA‐targeted anti‐cancer strategies have emerged continuously. Among them, RNA interference (RNAi) has been recognized as a promising therapeutic modality for various disease treatments. Nevertheless, the primary obstacle in siRNA delivery‐escaping the endosome and crossing the plasma membrane severely impedes its therapeutic potential. Thus far, a variety of nanosystems as well as carrier‐free bioconjugation for siRNA delivery have been developed and employed to enhance the drug delivery and anti‐tumor efficiency. Besides, the use of small molecules to target specific RNA structures and disrupt their function, along with the covalent modification of RNA, has also drawn tremendous attention recently owing to high therapeutic efficacy. In this review, we will provide an overview of recent progress in RNA‐targeted cancer therapy including various siRNA delivery strategies, RNA‐targeting small molecules, and newly emerged covalent RNA modification. Finally, challenges and future perspectives faced in this research field will be discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Centre of Radiation Medicine of Jiangsu Higher Education Institution…
- Department of Experimental Medicine, TOR, University of Rome Tor Vergata, Roma, 00133, Italy.
- Suzhou Industrial Park Institute of Services Outsourcing, Suzhou, 215123, China.
- Department of Ultrasound, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, 046000, China.
ORCID-Profile: Haibin Shi
Förderung
- National Natural Science Foundation of China
- Invigorating Medical through Science and Technology of Shanxi Province
- State Key Laboratory of Radiation Medicine and Protection
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Li, M., Zhu, J., Lv, Z., Qin, H., Wang, X., & Shi, H. (2024). Recent Advances in RNA‐Targeted Cancer Therapy. ChemBioChem, 25(4). https://doi.org/10.1002/cbic.202300633
Vancouver
Li M, Zhu J, Lv Z, Qin H, Wang X, Shi H. Recent Advances in RNA‐Targeted Cancer Therapy. ChemBioChem. 2024;25(4). doi:10.1002/cbic.202300633
BibTeX
@article{Li2024,
author = {Li, Miao and Zhu, Jinfeng and Lv, Zhengzhong and Qin, Hongni and Wang, Xiaoyan and Shi, Haibin},
title = {Recent Advances in RNA‐Targeted Cancer Therapy},
journal = {ChemBioChem},
year = {2024},
volume = {25},
number = {4},
doi = {10.1002/cbic.202300633}
}
EUVIMED